Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma of the Lungs”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableActive Not RecruitingNCT07202260
What this trial is testing

Pragmatic Analysis of Complex Radiotherapy Cases In Cancer of the Lung

Who this might be right for
Lung Cancer (NSCLC)Lung Cancer (SCLC)
The Christie NHS Foundation Trust 80
Testing effectiveness (Phase 2)Looking for participantsNCT05150691
What this trial is testing

A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors

Who this might be right for
HER2-positive Advanced Solid Tumor
DualityBio Inc. 796
Not applicableStudy completedNCT04451460
What this trial is testing

Effect of Hyponatremia in Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer
Ankara City Hospital Bilkent 466
Testing effectiveness (Phase 2)Study completedNCT03261947
What this trial is testing

Evaluate the Safety, Tolerability, and Activity of TAK-931 in Participants With Metastatic Pancreatic Cancer, Metastatic Colorectal Cancer, and Other Advanced Solid Tumors

Who this might be right for
Metastatic Pancreatic CancerColorectal CancerEsophageal Neoplasms+1 more
Millennium Pharmaceuticals, Inc. 101
Testing effectiveness (Phase 2)Looking for participantsNCT06706076
What this trial is testing

BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations

Who this might be right for
NSCLC (Advanced Non-small Cell Lung Cancer)
BlossomHill Therapeutics 675
Testing effectiveness (Phase 2)Study completedNCT03083691
What this trial is testing

BIOLUMA: Biomarkers for Nivolumab and Ipilimumab and Evaluation of the Combination in Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell LungCarcinoma, Small Cell Lung
Lung Cancer Group Cologne 90
Testing effectiveness (Phase 2)Study completedNCT02697591
What this trial is testing

INCAGN01876 in Participants With Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced MalignanciesMetastatic Cancer
Incyte Biosciences International Sàrl 100
Testing effectiveness (Phase 2)UnknownNCT04167774
What this trial is testing

Evaluate Camrelizumab in Combination With Nb-Paclitaxel in Patients With Advanced or Metastatic NSCLC

Who this might be right for
Non-Small Cell Lung Cancer
Sun Yat-sen University 62
Testing effectiveness (Phase 2)Looking for participantsNCT07306624
What this trial is testing

Nelmastobart in Combination With Docetaxel in Non Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
STCube, Inc. 62
Testing effectiveness (Phase 2)Study completedNCT04184921
What this trial is testing

Combination of Osimertinib and Aspirin to Treat EGFR Mutation NSCLC Patients

Who this might be right for
Lung Cancer Non-small Cell Stage IV
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University 216
Not applicableStudy completedNCT02364804
What this trial is testing

Evaluate the Efficacy of Anti-emetic Drug Upon the Combination Chemotherapy for Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Shiga University 10
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07631884
What this trial is testing

Exploratory Study on the Efficacy and Safety of Trastuzumab Rezetecan in the Treatment of HER2-Expressiong Advanced Solid Tumor

Who this might be right for
Solid TumorsNeoplasms (Cancer / Tumors)Advanced Malignant Solid Neoplasm+13 more
Haihua Yuan 15
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06971406
What this trial is testing

High-Dose Firmonertinib Combined With Bevacizumab and Intrathecal Pemetrexed in the Treatment of EGFR-Mutated Non-Small Cell Lung Cancer With Leptomeningeal Metastasis

Who this might be right for
Non Small Cell Lung CancerEGFR MutationLeptomeningeal Metastases+1 more
Qiming Wang 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT06205706
What this trial is testing

BI-1910 as a Single Agent and in Combination With Pembrolizumab for the Treatment of Advanced Solid Tumors

Who this might be right for
Solid TumorsNon Small Cell Lung CancerHepatocellular Carcinoma
BioInvent International AB 35
Testing effectiveness (Phase 2)Looking for participantsNCT05713006
What this trial is testing

Alectinib Pharmacokinetic in Patients With NSCLC

Who this might be right for
Non-small Cell Lung Cancer Stage IIIBALK Gene Mutation
Instituto Nacional de Cancerologia de Mexico 45
Large-scale testing (Phase 3)UnknownNCT04797806
What this trial is testing

Study of Anlotinib Combined With Icotinib as the First-line Treatment in Patients With EGFR Concomitant Mutation NSCLC

Who this might be right for
Non Small Cell Lung Cancer
Tianjin Medical University Cancer Institute and Hospital 206
Large-scale testing (Phase 3)Looking for participantsNCT07662395
What this trial is testing

SCTB41 Combined With Chemotherapy in Advanced Squamous Non-Small Cell Lung Cancer

Who this might be right for
Double Blind
Sinocelltech Ltd. 410
Testing effectiveness (Phase 2)UnknownNCT02733107
What this trial is testing

The Efficacy and Safety of Apatinib Combined With Etoposide in Heavily Pretreated Advanced Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Third Military Medical University 25
Testing effectiveness (Phase 2)Active Not RecruitingNCT04701307
What this trial is testing

Niraparib and Dostarlimab for the Treatment of Small Cell Lung Cancer and Other High-Grade Neuroendocrine Carcinomas

Who this might be right for
Lung Small Cell CarcinomaNeuroendocrine CarcinomaStage III Lung Cancer AJCC v8+3 more
M.D. Anderson Cancer Center 48
Very early researchWithdrawnNCT04870034
What this trial is testing

Binimetinib and Palbociclib Before Surgery for the Treatment of Operable KRAS-Positive Lung, Colorectal, or Pancreatic Cancer

Who this might be right for
Colorectal CarcinomaLung AdenocarcinomaMalignant Solid Neoplasm+1 more
Roswell Park Cancer Institute
Next Page